Showing results (191-200 of 283) with videos related to
Sort By:
Pageof 29
Plos Medicine|November 23, 2013
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer developmentAllison Jones, Andrew E Teschendorff, Quanxi Li, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 6, 2026
European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancerDavid Cibula, Anisa Mburu, François Planchamp, et al.Virchows Archiv : an International Journal of Pathology|May 5, 2018
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical CancerDavid Cibula, Richard Pötter, François Planchamp, et al.Gynecologic Oncology|January 9, 2021
Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIXIgnacio Zapardiel, Roman Kocian, Cristhardt Köhler, et al.Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic CategoriesPavel Dundr, Michaela Bártů, Tjalling Bosse, et al.International Journal of Cancer|December 19, 2022
The WID-EC test for the detection and risk prediction of endometrial cancerJames E Barrett, Allison Jones, Iona Evans, et al.The Lancet. Oncology|February 6, 2025
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trialAmit M Oza, Alla Lisyanskaya, Alexander Fedenko, et al.Virchows Archiv : an International Journal of Pathology|July 26, 2018
Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical CancerDavid Cibula, Richard Pötter, François Planchamp, et al.Gynecologic Oncology|August 28, 2024
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS studyLenka Fricová, Stefan Kommoss, Giovanni Scambia, et al.Pageof 29